{"transactions":[{"id":1259700,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-19T23:25:40.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":718800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":718800,"derivative":{"exercise_price":3.29,"expiration_date":"2035-02-14","underlying":"Common Shares","underlying_shares":718800},"source":{"system":"sec-edgar","filing":"0001447028-25-000051","document":"wk-form4_1740007534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000051/wk-form4_1740007534.xml","form_type":"4"}},{"id":1259699,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2025-02-19T23:25:40.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":177000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1658003,"source":{"system":"sec-edgar","filing":"0001447028-25-000051","document":"wk-form4_1740007534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000051/wk-form4_1740007534.xml","form_type":"4"}},{"id":1281713,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2025-02-05T21:02:29.000Z","date":"2025-02-04","kind":"sale","planned":true,"acquired":false,"shares":23790,"price":3.283,"value":78102.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 3, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units."}],"balance_after":1481003,"source":{"system":"sec-edgar","filing":"0001447028-25-000038","document":"wk-form4_1738789341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000038/wk-form4_1738789341.xml","form_type":"4"}},{"id":1658662,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:54:09.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":495100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":495100,"derivative":{"exercise_price":2.4,"expiration_date":"2034-02-01","underlying":"Common Shares","underlying_shares":495100},"source":{"system":"sec-edgar","filing":"0001447028-24-000025","document":"wk-form4_1707180834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000025/wk-form4_1707180834.xml","form_type":"4"}},{"id":1658661,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:09.000Z","date":"2024-02-02","kind":"sale","planned":true,"acquired":false,"shares":10164,"price":2.3125,"value":23504.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 3, 2023,  to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units."}],"balance_after":1504793,"source":{"system":"sec-edgar","filing":"0001447028-24-000025","document":"wk-form4_1707180834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000025/wk-form4_1707180834.xml","form_type":"4"}},{"id":1658660,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Shares","published_at":"2024-02-06T00:54:09.000Z","date":"2024-02-01","kind":"grant","planned":true,"acquired":true,"shares":123800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1514957,"source":{"system":"sec-edgar","filing":"0001447028-24-000025","document":"wk-form4_1707180834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000025/wk-form4_1707180834.xml","form_type":"4"}},{"id":2032765,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T21:12:10.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":334700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":334700,"derivative":{"exercise_price":2.9,"expiration_date":"2033-02-01","underlying":"Common Shares","underlying_shares":334700},"source":{"system":"sec-edgar","filing":"0001447028-23-000011","document":"wf-form4_167545871089009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000011/wf-form4_167545871089009.xml","form_type":"4"}},{"id":2032764,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Shares","published_at":"2023-02-03T21:12:10.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":83700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":1391157,"source":{"system":"sec-edgar","filing":"0001447028-23-000011","document":"wf-form4_167545871089009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000011/wf-form4_167545871089009.xml","form_type":"4"}},{"id":2430300,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T22:53:50.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":325850,"price":2.81,"value":915638.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":325850,"derivative":{"exercise_price":2.81,"expiration_date":"2032-01-20","underlying":"Common Shares","underlying_shares":325850},"source":{"system":"sec-edgar","filing":"0001447028-22-000007","document":"wf-form4_164271921610822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000007/wf-form4_164271921610822.xml","form_type":"4"}},{"id":2854285,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Options","published_at":"2021-02-17T21:55:01.000Z","date":"2021-02-13","kind":"grant","acquired":true,"shares":249000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":249000,"derivative":{"exercise_price":4.33,"expiration_date":"2031-02-13","underlying":"Common Stock","underlying_shares":249000},"source":{"system":"sec-edgar","filing":"0001447028-21-000006","document":"wf-form4_161359884797554.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000006/wf-form4_161359884797554.xml","form_type":"4"}},{"id":2869049,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-02-10T22:06:23.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020."}],"balance_after":1307457,"source":{"system":"sec-edgar","filing":"0001447028-21-000002","document":"wf-form4_161299476323256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000002/wf-form4_161299476323256.xml","form_type":"4"}},{"id":2942376,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-16T21:33:56.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":10000,"price":5.0032,"value":50032.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020."}],"balance_after":1327457,"source":{"system":"sec-edgar","filing":"0001447028-20-000152","document":"wf-form4_160815442050068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000152/wf-form4_160815442050068.xml","form_type":"4"}},{"id":2942375,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-16T21:33:56.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":30000,"price":5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020."}],"balance_after":1337457,"source":{"system":"sec-edgar","filing":"0001447028-20-000152","document":"wf-form4_160815442050068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000152/wf-form4_160815442050068.xml","form_type":"4"}},{"id":3075550,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-07-27T21:27:45.000Z","date":"2020-07-23","kind":"sale","acquired":false,"shares":20000,"price":5.01,"value":100200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020."}],"balance_after":1367457,"source":{"system":"sec-edgar","filing":"0001447028-20-000080","document":"wf-form4_159588525290974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000080/wf-form4_159588525290974.xml","form_type":"4"}},{"id":3262953,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Options","published_at":"2020-02-19T13:02:36.000Z","date":"2020-02-17","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest and become exercisable 1/48th each month over the four year period."}],"balance_after":200000,"derivative":{"exercise_price":3.35,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001447028-20-000026","document":"wf-form4_158211733691572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000026/wf-form4_158211733691572.xml","form_type":"4"}},{"id":3612038,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":83055,"kind":"person","name":"McElhaugh Michael J.","position":1,"cik":"0001635326","reported_name":"McElhaugh Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-05T23:07:54.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":104500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable in three equal annual installments beginning March 1, 2020."}],"balance_after":104500,"derivative":{"exercise_price":4.57,"expiration_date":"2029-03-01","underlying":"Common Shares","underlying_shares":104500},"source":{"system":"sec-edgar","filing":"0001123292-19-000436","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000112329219000436/edgar.xml","form_type":"4"}}]}